Psychiatric Diagnosis, Validation Studies
Conditions
Keywords
Cross-cultural adaptation, Child and adolescente psychiatry, mental health care assessment,, Translation, Validation
Brief summary
This is an observational study that will be responsible for the Spanish translation and cross-cultural adaptation, and validation of the Electronic Semi-Structured Psychiatric Interview for Children and Adolescents (EPSI-C), to examine, classify, prioritize, and diagnose patients.
Detailed description
This study, part of the DADAP project, aims to transform the diagnostic evaluation process in the clinical care pathway of child and adolescent psychiatry (CAP) by digitizing and automating it through an innovative solution based on explainable artificial intelligence that optimizes the delivery of health services and care in a wide range of different settings. This study is a real-world, prospective, multicenter, single-arm observational study that has gathered an international consortium formed by Sweden, Norway, Spain, and Romania. Each participating country is responsible for a specific work package. Our research team is in charge of WP1, which involves the Spanish translation, validation, and cross-cultural adaptation of the Electronic Semi-Structured Psychiatric Interview for Children and Adolescents (EPSI-C). The semi-structured interview EPSI-C was developed in collaboration between the Child and Adolescent Psychiatric Clinic and the Centre for Clinical Research in Region Västmanland, Sweden. It is based on the DSM-5 diagnostic classification, and it will be used to diagnose young people aged 6 to 17. The Spanish team is also responsible for WP4, which involves validating the feasibility of the EPSI-C tool both across and within countries through a pilot study, integrating new technologies and artificial intelligence to improve diagnostic processes.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
\- Families and children aged 6 to 17 with a mental health referral from primary care.
Exclusion criteria
* Minors under state care without stable attachment figures to report clinical history. * Presence of global developmental disorder or moderate to severe intellectual disability. * Incomplete, inaccurate, or unclear medical data.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Child and adolescent psychiatric assessment | At baseline | EPSI-C (Electronic Semi-Structured Psychiatric Interview for Children and Adolescents). A semi-structured diagnostic interview that assesses current episodes of psychopathology in children and adolescents aged 6 to 17 years according to the DSM-5 diagnostic criteria. The mental disorders assessed by the EPSI-C are: specific phobia, separation anxiety disorder, social anxiety disorder, panic disorder, agoraphobia, generalized anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder (PTSD) and complex PTSD (according to ICD-11 criteria), major and persistent depression, manic/hypomanic episode, anorexia nervosa, bulimia nervosa, binge eating disorder, attention deficit hyperactivity disorder (ADHD), autism spectrum disorder, Tourette's disorder/tics, oppositional defiant disorder, and conduct disorder. It also includes screening for psychotic disorders and self-harm. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Content validity | At baseline | Questionnaire for the Evaluation of the Content Validity of the EPSI-C. The questionnaire evaluates qualitative assessment (comprehension and wording clarity) and quantitative assessment ( Coherence, clarity, sufficiency, and relevance). |
| Patient acceptability | At baseline | Ad-hoc patient questionnaire with open-ended items assessing clarity, relevance, comfort, length, and overall satisfaction Patient-rated satisfaction and acceptability of the culturally adapted EPSI-C after completing the pilot administration. |
| Feasibility of the EPSI-C | At baseline | Feasibility of EPSI-C measured by mean score on an ad-hoc clinician evaluation form (Likert 1-4). Clinician-rated acceptability, feasibility, and perceived clinical relevance, clarity, and time length after EPSI-C administration in clinical/pilot settings. |
Countries
Spain
Contacts
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud